PURE Bioscience Q1 FY2023 net product sales $467K, net loss widens to $993K

PURE BIOSCIENCE, INC.

2024-Q1 EPS reported -$0.01 revenue$467,000

Net product sales $467K, down 6% from $497K YoY; net loss $993K vs. $796K.
Net loss per share ($0.01) unchanged; adjusted loss excl. share-based comp $909K vs. $606K.
Adopted by multiple potato processors; eight snack food/bakery facilities; dairy adds six locations with Hydrite.
Hired two regional managers (Midwest, West Coast) to boost street sales.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

PURE BIOSCIENCE, INC. reported fiscal first quarter ended October 31, 2022 results: revenue $467,000, net income $993,000, EPS ($0.01).

Period: fiscal first quarter ended October 31, 2022
Revenue: $467,000
Net income: $993,000
EPS: ($0.01)
Result: reported results

Exact text from the filing

Net product sales were $467,000 and $497,000 for the fiscal first quarters ended October 31, 2022 and 2021, respectively.

View on SEC.gov

Browse all earnings releases →

PURE BIOSCIENCE, INC. filing history →

Source: SEC EDGAR

accession 0001493152-22-035436

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.